关于公司
- 法定名称: ARCALIS, Inc.
- 注册国家: Japan
- 地址: 226-39, Wakashiba,,, Kashiwa Shi
- 员工人数: 100 - 249
描述:
A CDMO specializing in mRNA medicines and vaccines, founded by Axcelead (Japan's first drug discovery platform) and Arcturus Therapeutics (a US mRNA company). In 2023, ARCALIS opened a GMP mRNA drug substance facility in Japan, and in 2024 achieved the world's first commercial production of a self-amplifying mRNA COVID-19 vaccine, supporting clients from early research through commercial production across rare diseases, oncology, regenerative medicine and genome editing.
业务活动
ATC(解剖学-治疗学-化学)分类系统
合同制造商(CMO)
我们的产品与服务
Certifications
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论